Related Experiment Video
Updated: Jul 8, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Undercarboxylated osteocalcin and bone mass in 8-12 year old children with cystic fibrosis
M S Fewtrell1, C Benden2, J E Williams1
1MRC Childhood Nutrition Research Centre, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK.
Insights
Young adults with cystic fibrosis (CF) may have bone disease due to poor vitamin K status. This study found higher levels of undercarboxylated osteocalcin (uc-OC), indicating low vitamin K, linked to lower bone mass in children with CF.
Area of Science:
- Pediatric endocrinology
- Bone metabolism
- Nutritional deficiencies
Background:
- Cystic fibrosis (CF) is associated with an increased risk of bone disease in young adults.
- Suboptimal vitamin K status and impaired osteocalcin carboxylation are hypothesized contributors to CF-related bone abnormalities.
Purpose of the Study:
- To investigate bone mineralization and turnover in children with CF.
- To assess the relationship between vitamin K status and bone health markers in this population.
Main Methods:
- Dual-energy X-ray absorptiometry (DXA) for bone mineral density (BMD) and bone mineral content (BMC) of the whole body and lumbar spine (LS).
- Measurement of 25-OH Vitamin D, parathyroid hormone (PTH), plasma osteocalcin, and pro-peptide of type 1 collagen (P1NP).
- Assessment of vitamin K status using undercarboxylated osteocalcin (% uc-OC).
Main Results:
- 20% of CF patients aged 8-12 years had LS BMD Z-scores below -1.0.
- Size-adjusted bone mass was generally normal, but % uc-OC was elevated and P1NP was decreased compared to reference data.
- Higher % uc-OC was significantly associated with lower size-adjusted LS bone mineral content and LS bone mineral apparent density.
Conclusions:
- Children with CF exhibit markers of suboptimal vitamin K status and reduced bone formation, even with normal size-adjusted bone mass.
- The correlation between LS bone mineral content and % uc-OC supports the hypothesis that vitamin K deficiency is a risk factor for bone disease in CF.
- Further intervention trials are recommended to confirm these findings and explore therapeutic strategies.
Unlabelled:
Young adults with cystic fibrosis (CF) frequently develop bone disease. One suggested aetiological factor is suboptimal vitamin K status with impaired carboxylation of osteocalcin and abnormal bone formation.
Methods:
We measured bone mineralization and turnover in thirty-two 8-12 year old CF patients (14 boys) using Dual Energy X-ray absorptiometry (whole body (WB) and lumbar spine (LS)), 25-OH Vitamin D, PTH and markers of bone formation (plasma osteocalcin, N-terminal pro-peptide of type 1 collagen (P1NP)), plus an indirect measure of vitamin K status, undercarboxylated osteocalcin (uc-OC).
Results:
LS bone mineral density (BMD) standard deviation (SD) scores were < -1.0 in 20% of subjects. Size-adjusted LS and WB bone mass was normal. Compared to reference data, % uc-OC was high and P1NP low. LS bone mass was predicted by % uc-OC but not other markers (0.4% decrease in size-adjusted LSBMC (p=0.05); 0.04 SD decrease in LSBMAD (p=0.04) per 1% increase in uc-OC).
Conclusion:
Markers suggestive of sub-optimal vitamin K status and low bone formation were present despite normal size-adjusted bone mass. The association between LSBMC and % uc-OC is consistent with the hypothesis that sub-optimal vitamin K status is a risk factor for CF bone disease. This should ideally be investigated in an intervention trial.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Bone Remodeling